Arterial wall lymphangiogenesis is increased in the human iliac atherosclerotic arteries: Involvement of CCR7 receptor

Lymphatic Research and Biology

Volumn 12, Issue 4, 2014, Pages 222-231

  Grzegorek, Irmina ^a,b   Drozdz, Katarzyna ^a,c   Chmielewska, Magdalena ^a,b   Gomulkiewicz, Agnieszka ^a,b   Jablonska, Karolina ^a,b   Piotrowska, Aleksandra ^a,b   Karczewski, Maciej ^a,d   Janczak, Dariusz ^a,b,c   Podhorska Okolow, Marzena ^a,b   Dziegiel, Piotr ^a,b   Szuba, Andrzej ^a,b,c  

^a Center of Research and Development   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c 4TH MILITARY HOSPITAL   (Poland)

^d Illimites Foundation   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; LYVE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; BIOLOGICAL MARKER; CCR7 PROTEIN, HUMAN; LYVE1 PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTERIAL WALL THICKNESS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MIGRATION; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; HYPERTENSION; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; LEG ISCHEMIA; LYMPHANGIOGENESIS; LYMPHOCYTE; MACROPHAGE; MEDICAL HISTORY; OPTICAL DENSITY; ORGAN DONOR; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; INTIMA; LYMPH VESSEL; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; ILIAC ARTERY; IMMUNOENZYME TECHNIQUES; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CCR7; RISK FACTORS; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VESICULAR TRANSPORT PROTEINS;

EID: 84918576876     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2013.0048     Document Type: Article

References (29)

1. Gaziano T, Reddy KS, Paccaud F, Horton S, . Cardiovascular Disease. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 33
2. Nakano T, Nakashima Y, Yonemitsu Y, et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 2005;36:330-340
3. Drozdz K, Janczak D, Dziegiel P, et al. Adventitial lymphatics of internal carotid artery in healthy and atherosclerotic vessels. Folia Histochem Cytobiol 2008;46: 433-436
4. Schoppmann SF. Lymphangiogenesis, inflammation and metastasis. Anticancer Res 2005;25:4503-4511
5. Sweat RS, Stapor PC, Murfee WL. Relationships between lymphangiogenesis and angiogenesis during inflammation in rat mesentery microvascular networks. Lymphat Res Biol 2012;10:198-207
6. Mouta C, Heroult M. Inflammatory triggers of lymphangiogenesis. Lymphat Res Biol 2003;1:201-218
7. Xu X, Lu H, Lin H, et al. Aortic adventitial angiogenesis and lymphangiogenesis promote intimal inflammation and hyperplasia. Cardiovasc Pathol 2009;18:269-278
8. Nordestgaard BG, Hjelms E, Stender S, Kjeldsen K. Different efflux pathways for high and low density lipoproteins from porcine aortic intima. Arteriosclerosis 1990;10:477-485
9. Nanjee MN, Cooke CJ, Wong JS, Hamilton RL, Olszewski WL, Miller NE. Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: Quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res 2001;42:639-648
10. Zhao B, Cui K, Wang CL, et al. The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. J Hepatobiliary Pancreat Sci 2011;18:821-828
11. Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 2004;101: 11779-11784
12. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci USA 2006;103:3781-3786
13. Feig JE, Pineda-Torra I, Sanson M, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 2010;120:4415-4424
14. Feig JE, Rong JX, Shamir R, et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci USA 2011;108:7166-7171
15. Feig JE, Shang Y, Rotllan N, et al. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS One 2011;6:e28534
16. Luchtefeld M, Grothusen C, Gagalick A, et al. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation 2010;122:1621-1628
17. Yamashita M, Iwama N, Date F, et al. Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol 2009; 40:1553-1563
18. Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-Talk promote invasive phenotype. Cancer Res 2009;69:349-357
19. Remmele N, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. De Pathologe 1987;8:138-140
20. Wan W, Lionakis MS, Liu Q, Roffê E, Murphy PM. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Cardiovasc Res 2013;97:580-588
21. Subbotin VM. Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: A hypothesis. Theor Biol Med Model 2012;9:11
22. Drozdz K, Janczak D, Dziegiel P, et al. Adventitial lymphatics and atherosclerosis. Lymphology 2012;45:26-33
23. Attout T, Hoerauf A, Dénécé G, et al. Lymphatic vascularisation and involvement of Lyve-1 + macrophages in the human onchocerca nodule. PLoS One 2009;4:e8234
24. Xu X, Lu H, Lin H, et al. Lymphangiogenesis promotes inflammation and neointimal hyperplasia after adventitia removal in the rat carotid artery. Int J Cardiol 2009;134: 426-427
25. Bhardwaj S, Roy H, Heikura T, Ylä-Herttuala S. VEGF-A, VEGF-D and VEGF-D (DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 2005;35: 6676
26. Takekoshi T, Fang L, Paragh G, Hwang ST. CCR7-expressing B16 melanoma cells downregulate interferon-cmediated inflammation and increase lymphangiogenesis in the tumor microenvironment. Oncogenesis 2012;1:e9
27. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010;140:460-476
28. Feng Y, Hu J, Ma J, et al. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer 2011;47:2353-2363
29. Yan C, Zhu ZG, Yu YY, et al. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World J Gastroenterol 2004;10: 783-790